236 related articles for article (PubMed ID: 32725316)
1. Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study.
Barczewska M; Maksymowicz S; Zdolińska-Malinowska I; Siwek T; Grudniak M
Stem Cell Rev Rep; 2020 Oct; 16(5):922-932. PubMed ID: 32725316
[TBL] [Abstract][Full Text] [Related]
2. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.
Petrou P; Kassis I; Yaghmour NE; Ginzberg A; Karussis D
Front Biosci (Landmark Ed); 2021 Oct; 26(10):693-706. PubMed ID: 34719198
[No Abstract] [Full Text] [Related]
3. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
[TBL] [Abstract][Full Text] [Related]
4. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
6. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
[TBL] [Abstract][Full Text] [Related]
7. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
8. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice.
Wang J; Hu W; Feng Z; Feng M
Neurol Res; 2021 Mar; 43(3):199-209. PubMed ID: 33076784
[TBL] [Abstract][Full Text] [Related]
9. A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease.
Soder RP; Dawn B; Weiss ML; Dunavin N; Weir S; Mitchell J; Li M; Shune L; Singh AK; Ganguly S; Morrison M; Abdelhakim H; Godwin AK; Abhyankar S; McGuirk J
Stem Cell Rev Rep; 2020 Oct; 16(5):979-991. PubMed ID: 32740891
[TBL] [Abstract][Full Text] [Related]
10. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.
Staff NP; Madigan NN; Morris J; Jentoft M; Sorenson EJ; Butler G; Gastineau D; Dietz A; Windebank AJ
Neurology; 2016 Nov; 87(21):2230-2234. PubMed ID: 27784774
[TBL] [Abstract][Full Text] [Related]
11. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
12. Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy.
Barczewska M; Grudniak M; Maksymowicz S; Siwek T; Ołdak T; Jezierska-Woźniak K; Gładysz D; Maksymowicz W
Neural Regen Res; 2019 Feb; 14(2):313-318. PubMed ID: 30531015
[TBL] [Abstract][Full Text] [Related]
13. Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.
Özmert E; Arslan U
Stem Cell Res Ther; 2020 Jan; 11(1):25. PubMed ID: 31931872
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
Karussis D; Karageorgiou C; Vaknin-Dembinsky A; Gowda-Kurkalli B; Gomori JM; Kassis I; Bulte JW; Petrou P; Ben-Hur T; Abramsky O; Slavin S
Arch Neurol; 2010 Oct; 67(10):1187-94. PubMed ID: 20937945
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
[TBL] [Abstract][Full Text] [Related]
19. Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis.
De Marchi F; Mareschi K; Ferrero I; Cantello R; Fagioli F; Mazzini L
Cytotherapy; 2023 Aug; 25(8):798-802. PubMed ID: 36931995
[TBL] [Abstract][Full Text] [Related]
20. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
